Enanta Pharmaceuticals Inc Share Price Today: Live Updates & Key Insights
Enanta Pharmaceuticals Inc share price today is $12.78, up -1.31%. The stock opened at $12.84 against the previous close of $12.95, with an intraday high of $12.94 and low of $12.655.
Enanta Pharmaceuticals Inc Share Price Chart
Enanta Pharmaceuticals Inc
Enanta Pharmaceuticals Inc Share Price Performance
Enanta Pharmaceuticals Inc Institutional Holdings
Enanta Pharmaceuticals Inc Market Status
Enanta Pharmaceuticals Inc Fundamentals
Market Cap 376.57 M
PB Ratio 3.2598
PE Ratio 0.0
Enterprise Value 272.82 M
Total Assets 280.73 M
Volume 104646
Enanta Pharmaceuticals Inc Company Financials
About Enanta Pharmaceuticals Inc & investment objective
Company Information Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for virology and immunology indications. The company's product pipeline comprises EDP-514, which is in phase 1b clinical development for the treatment of chronic infection with hepatitis B virus or HBV; zelicapavir and EDP-323, which is in phase II clinical development for the treatment of respiratory syncytial virus; EDP-235, which is in phase II clinical development for the treatment of human coronaviruses; EDP-978 for chronic spontaneous urticaria (CSU); Glecaprevir, antiviral protease inhibitors for the treatment of chronic infection with hepatitis C virus or HCV; and EPS-3903 for the treatment of atopic dermatitis. It has a collaborative development and license agreement with Abbott Laboratories to develop, manufacture, and commercialize HCV NS3 and NS3/4A protease inhibitor compounds, including paritaprevir and glecaprevir. The company was incorporated in 1995 and is headquartered in Watertown, Massachusetts.
Organisation Biotechnology
Employees 120
Industry Biotechnology
CEO Dr. Jay R. Luly Ph.D.
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Enanta Pharmaceuticals Inc FAQs
What is the share price of Enanta Pharmaceuticals Inc today?
The current share price of Enanta Pharmaceuticals Inc is $12.78.
Can I buy Enanta Pharmaceuticals Inc shares in India?
Yes, Indian investors can buy Enanta Pharmaceuticals Inc shares by opening an international trading and demat account with Motilal Oswal.
How to buy Enanta Pharmaceuticals Inc shares in India?
You can easily invest in Enanta Pharmaceuticals Inc shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Enanta Pharmaceuticals Inc shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Enanta Pharmaceuticals Inc.
Can I buy fractional shares of Enanta Pharmaceuticals Inc?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Enanta Pharmaceuticals Inc?
Enanta Pharmaceuticals Inc has a market cap of $376.57 M.
In which sector does Enanta Pharmaceuticals Inc belong?
Enanta Pharmaceuticals Inc operates in the Biotechnology sector.
What documents are required to invest in Enanta Pharmaceuticals Inc stocks?
To invest, you typically need:
What is the PE and PB ratio of Enanta Pharmaceuticals Inc?
The PE ratio of Enanta Pharmaceuticals Inc is N/A and the PB ratio is 3.26.